Category: basic life sciences retractions

BMC investigating allegedly copied paper

logoBioMed Central is investigating a recent paper about a potential biomarker for liver cancer, which shows signs it was written using another article as a template.

According to Jeffrey Beall, who exposed the similarities between the two papers on his blog Scholarly Open Access yesterday, the paper in question is “obviously bogus,” and appears to have relied on the “template plagiarism” technique of creating a new article by modifying a previous paper’s text and data.

A spokesperson for BioMed Central, which published the allegedly “junk” paper, as Beall calls it, told us they are looking into the allegations: Continue reading BMC investigating allegedly copied paper

Prostate cancer paper flagged by ORI is retracted following PETA prompt

cover_issue_129_en_USA federal investigation into a paper on prostate cancer has now led to a retraction. In an unusual twist, it happened following a request from the animal rights group People for the Ethical Treatment of Animals (PETA).

In January, the Office of Research Integrity reported that corresponding author Dong Xiao “intentionally fabricated data” in an Oncotarget study of how a steroid inhibits the growth of prostate cancer. Xiao, a former cancer researcher at the University of Pittsburgh, claimed that he had tumor data from more mice than he did, and falsified several figures.

In July, after no sign of the retraction, a researcher at PETA followed up with the journal, Oncotarget, on behalf of the organization “and our more than 3 million members and supporters to request the immediate retraction.”

Last month, they received a reply from the publisher, which they forwarded to us:

Continue reading Prostate cancer paper flagged by ORI is retracted following PETA prompt

Former ob-gyn prof notches ninth retraction; investigation still underway

Nasser Chegini
Nasser Chegini

A retired obstetrics and gynecology professor under federal investigation for misconduct has notched his ninth retraction.

The latest retraction stems from an investigation by the University of Florida, where Nasser Chegini worked until 2012, which found fabricated data in three figures in a paper on the muscle cells that line the uterus.

The paper, “Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids,” was published in The Journal of Cellular and Molecular Medicine. It’s been cited 74 times, according to Thomson Scientific’s Web of Knowledge.

Here’s the note:

Continue reading Former ob-gyn prof notches ninth retraction; investigation still underway

“Insufficient permission” from funder resects liver disease paper

HepatologyA study on chronic liver inflammation was pulled from the journal Hepatology because of “insufficient permission by the authors’ funding institution to submit and publish the manuscript.” 

The paper, which was published in July, looked into how steatosis, the abnormal retention of fat in the liver, turns into steatohepatitis, also known as fatty liver disease. Researchers found that Treg cells play a central role in controlling the disease.

Unfortunately, the journal’s managing editor didn’t provide any information about the nature of the permission problems, and the notice doesn’t give any details.

Here it is, in full:

Continue reading “Insufficient permission” from funder resects liver disease paper

Failure to reproduce key experiments retracts cancer study

Medical OncologyA group of Chinese cancer researchers has retracted a paper in Medical Oncology after they discovered that “several key experiments” were not reproducible.

The paper, “Decreased Warburg effect induced by ATP citrate lyase suppression inhibits tumor growth in pancreatic cancer,” was published in March. It found that suppressing the enzyme ATP citrate lyase could be used to treat pancreatic cancer.

However, the authors decided to pull the paper when some of the findings couldn’t be reproduced. 

Here’s the notice:

Continue reading Failure to reproduce key experiments retracts cancer study

Journal mistakenly publishes Parkinson’s case report twice

Journal of Movement Disorders

A journal has retracted a duplicate version of a case report about a patient with Parkinson’s disease after mistakenly publishing the paper twice.

The Journal of Movement Disorders initially published the report — which detailed the case of an elderly woman with Parkinson’s disease whose symptoms worsened during drug treatment — in 2010. But it ended up printing it again in 2011 because of “a mistake of the editorial office and the publisher.”

The notice reads:

Continue reading Journal mistakenly publishes Parkinson’s case report twice

Much of preclinical research into one cancer drug is flawed, says report

elife-identity-headerA review of preclinical research of a now widely used cancer drug suggests the studies contain multiple methodology flaws and overestimate the benefits of the drug.

Specifically, the researchers found that most studies didn’t randomize treatments, didn’t blind investigators to which animals were receiving the drug, and tested tumors in only one animal model, which limits the applicability of the results. Importantly, they also found evidence that publication bias — keeping studies that found no evidence of benefit from the drug, sunitinib, out of the literature — may have caused a significant overestimation of its effects on various tumor types.

Together, these findings suggest the need for a set of standards that cancer researchers follow, the journal notes in a “digest” of the paper, published Tuesday by eLife:
Continue reading Much of preclinical research into one cancer drug is flawed, says report

Nature: No plans to change wording of STAP retractions

cover_nature (2)Despite acknowledging in its own pages that two recent high-profile retraction notices turned out to not tell the whole story, Nature will not be updating the original retraction notices, the journal tells us.

We checked in with Nature after it published two Brief Communications Arising regarding two high-profile retractions of papers describing a new method of reprogramming cells to a pluripotent state. (This method is also known as stimulus-triggered acquisition of pluripotency, or STAP.)

We were particularly intrigued by the journal’s plans for the retractions, published in 2014, when an editorial in the September 23 issue about the new BCAs (here and here) suggested the wording of the notices might be problematic: Continue reading Nature: No plans to change wording of STAP retractions

13th retraction issued for Jesús Ángel Lemus

Proceedings of the Royal Society B- Biological SciencesA 13th retraction has been published for Jesús Ángel Lemus, the Spanish veterinary researcher whose work colleagues have had trouble verifying.

This paper was pulled for similar reasons as his other retractions: After retrying the experiments in two independent labs, fellow authors were “unable to arrive to any sound conclusion about the validity of his analyses.” 

Proceedings of the Royal Society B: Biological Sciences posted the notice September 16, three years after the paper received an expression of concern.

The retraction notice, signed by every co-author but Lemus, reads:

Continue reading 13th retraction issued for Jesús Ángel Lemus

Mystery: PLOS One seeks investigation after publishing two papers with “substantial overlap”

Screen Shot 2015-10-01 at 4.27.21 PMPLOS One has retracted one of two cancer papers with “substantial overlap” that were reviewed simultaneously by different editors.

This one’s a bit of a mystery — neither of the papers share an author, and no authors share institutions. Once the editors discovered the overlap, they contacted the authors. One group of authors provided the requested documentation for the experiments. The other did not — so the editors retracted that article, even though it was published months before the other one.

In the meantime, the editors have asked the authors’ institutions investigate how the articles — which contain entire identical sentences, and some extremely similar figures — were put together. According to a statement from the editors:

Continue reading Mystery: PLOS One seeks investigation after publishing two papers with “substantial overlap”